Uniform Multidrug Therapy Regimen for Leprosy Patients
Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this randomized trial is to verify if leprosy patients, despite of their
classification, can be treated with the same regimen without compromising patient cure and
acceptability of the treatment. At present, patients classified as multibacillary leprosy are
treated for 12 months with three drugs, and patients classified as paucibacillary leprosy are
treated for 6 months with two drugs. The study is going to test a unified regimen for
paucibacillary and multibacillary patients by treating leprosy patients with three drugs for
6 doses.
Phase:
Phase 4
Details
Lead Sponsor:
University of Brasilia
Collaborators:
Conselho Nacional de Desenvolvimento Científico e Tecnológico Fundação Alfredo da Matta, Manaus, Brazil Instituto de Dermatologia Dona Libania, Fortaleza, Brazil Ministry of Health, Brazil Ministry of Science and Technology, Brazil